Biden-era policies rescinded by Donald Trump could signal a significant shake-up in Medicare and Medicaid drug price reforms.
President Donald Trump rescinded an executive order issued by former President Joe Biden aimed at finding new models for ...
Of the scores of day-one executive orders (EOs) issued by President Trump, the order rescinding a Biden administration executive order on ...
The Center for Medicare and Medicaid Innovation had started the process of enrolling states in the pilot program, and the application process was expected to be open through Feb. 28. Read ...
Stroke remains a global health challenge, ranking second in worldwide mortality and fifth in U.S. deaths. In response, researchers at Ochsner Health, led by Hernan Bazan, MD, DFSVS, FACS, have ...
For the almost 520,000 Americans who will undergo treatment this year, the process leaves little room for a full life. An ...
Where can researchers look for a beacon of hope amid trying times in the pharmaceutical industry? Read on for answers.
An early move by the president has raised questions about what direction his second-term policy on drug costs will take.
Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...
New letters urge the Centers for Medicare & Medicaid Services to expand Medicare and Medicaid to include FDA-approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback